VERADIGM INC (MDRX) Stock News

Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025

Mentions: OTC

Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency

Mentions: OTC

Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

Mentions: OTC

Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025

Mentions: OTC

Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements

Mentions: OTC

Veradigm to Release Financial Update March 18th and Host Investor Call March 19th

Mentions: OTC

Over 3,500 Healthcare Practices Receive Gaps-in-Care Alerts at the Point-of-Care via Veradigm Payer Insights Solution

Mentions: OTC

Veradigm Becomes First EHR Media Platform to Achieve POCMA Certification

Mentions: OTC

Veradigm Announces Board Expansion and Changes

Mentions: OTC

Veradigm Amends and Extends Stockholder Rights Plan

Mentions: OTC

Veradigm Introduces Cardiometabolic Clinical Registry Datasets to Enhance the Next Generation of Real-World Research

Mentions: OTC

Black Book Ranks Veradigm EHR the #1 Ambulatory EHR for Family Practice and Primary Care Practices

Mentions: OTC

Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review

Mentions: OTC

Veradigm Announces the Resignation of Board Director Beth Altman Due to Health Reasons

Mentions: OTC

Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey

Mentions: OTC

Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX)

Mentions: OTC

Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden

Mentions: OTC

Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration

Mentions: OTC

Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data

Mentions: OTC

Automated Medical Chart Retrieval Expands to 300,000+ U.S. Healthcare Providers via Veradigm eChart Courier

Mentions: OTC

Veradigm Ranked Top Vendor by KLAS

Mentions: OTC

Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions

Mentions: OTC

Positive Impact Observed at Many Orthopedic Practices Utilizing Veradigm Coding Services

Mentions: OTC

Black Book ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solutions Vendor in 2024

Mentions: OTC

Robbins LLP Reminds MDRX Stockholders it is Investigating the Officers and Directors of Veradigm Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders

Robbins LLP Informs Investors it is Investigating the Officers and Directors of Veradigm Inc. (MDRX) for Breaches of Fiduciary Duty

VERADIGM ALERT: Bragar Eagel & Squire, P.C. is Investigating Veradigm Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Veradigm Payerpath Rated Highest in Client Satisfaction

Mentions: OTC

Veradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance

Mentions: OTC

Veradigm Announces Leadership Updates

Mentions: OTC

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

Law Offices of Howard G. Smith Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Veradigm Inc. (MDRX) on Behalf of Investors

Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings

Mentions: OTC

Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation

/PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc., f.k.a. Allscripts Healthcare...

Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mentions: OTC

Veradigm Announces Initial Financial Guidance for Fiscal 2024

Mentions: OTC

Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference

Mentions: OTC

Veradigm Completes Acquisition of ScienceIO

Mentions: OTC

Veradigm Receives Expected Delisting Notice from Nasdaq